The Impact of Aztreonam-clavulanic Acid Exposure on Gene Expression and Mutant Selection Using a Multidrug-resistant

Overview

Journal Microbiol Spectr

Specialty Microbiology

Date 2025 Feb 11

PMID 39932309

Authors

Tongtong Lin

Jiayuan Zhang

Shuo Diao

Jinke Yan

Kexin Zhang

Jichao Cao

Junyi Huang

Yaohai Wang

Zhihua Lv

Xiaopeng Shen

Sherwin K B Sy

Michael Lynch

Hongan Long

Mingming Yu

Affiliations

Soon will be listed here.

Abstract

Multidrug-resistant poses a significant threat to the healthcare system by causing treatment failure in infected patients. The use of a beta-lactam in combination with a beta-lactamase inhibitor has been shown to be an effective strategy to solve this problem. antimicrobial susceptibility experiments have demonstrated the antimicrobial activity of aztreonam and clavulanate. In this investigation, we conducted a transcriptomic analysis to reveal the downstream differential gene expression in ymmD45 (a strain newly isolated and found to carry the New Delhi metallo-β-lactamase gene) following exposure to aztreonam and clavulanate separately, as well as their combination. Differential gene expression, pathway enrichment, and gene network analyses demonstrated the polygenic nature of the response to the combination treatment, which suppressed the expression of pivotal virulence genes, disrupted two-component regulatory systems for bacteria to resist external stress, and interfered with the formation of the cellular membrane. Results from single-step mutant selection combined with deep whole-genome sequencing also revealed the spontaneous origin of the resistance mutations and confirmed action mechanisms during the combination treatment. Our study contributes valuable insights into the impact of antibiotic exposure on gene expression, laying the groundwork for understanding antibiotic resistance development in the treatment of multi-drug resistant infections through studies.IMPORTANCEMultidrug-resistant is a major challenge in treating infections effectively. Aztreonam and clavulanate combination is promising in combating these resistant bacteria. By investigating the antimicrobial activity of aztreonam and clavulanate using transcriptomic analysis and mutant selection, this research sheds light on the mechanisms underlying antibiotic resistance and the effectiveness of combination therapies. The findings highlight how this particular antibiotic combination suppresses virulence genes, disrupts bacterial regulatory systems, and interferes with cellular functions critical for resistance. Moreover, the study lays the groundwork for understanding antibiotic resistance development in the treatment of multi-drug resistant infections through studies, offering insights that could inform future strategies in clinical settings. Ultimately, our findings could guide the development of better treatment strategies for multidrug-resistant infections, improving patient outcomes and helping to manage antibiotic resistance in healthcare.

References

Alcock B, Huynh W, Chalil R, Smith K, Raphenya A, Wlodarski M . CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database. Nucleic Acids Res. 2022; 51(D1):D690-D699. PMC: 9825576. DOI: 10.1093/nar/gkac920. View

Falconi M, Prosseda G, Giangrossi M, Beghetto E, Colonna B . Involvement of FIS in the H-NS-mediated regulation of virF gene of Shigella and enteroinvasive Escherichia coli. Mol Microbiol. 2001; 42(2):439-52. DOI: 10.1046/j.1365-2958.2001.02646.x. View

Petty N, Ben Zakour N, Stanton-Cook M, Skippington E, Totsika M, Forde B . Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A. 2014; 111(15):5694-9. PMC: 3992628. DOI: 10.1073/pnas.1322678111. View

Mauri C, Maraolo A, Di Bella S, Luzzaro F, Principe L . The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases. Antibiotics (Basel). 2021; 10(8). PMC: 8388901. DOI: 10.3390/antibiotics10081012. View

Thorvaldsdottir H, Robinson J, Mesirov J . Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2012; 14(2):178-92. PMC: 3603213. DOI: 10.1093/bib/bbs017. View

Finlay J, Miller L, Poupard J . A review of the antimicrobial activity of clavulanate. J Antimicrob Chemother. 2003; 52(1):18-23. DOI: 10.1093/jac/dkg286. View

Mikheenko A, Prjibelski A, Saveliev V, Antipov D, Gurevich A . Versatile genome assembly evaluation with QUAST-LG. Bioinformatics. 2018; 34(13):i142-i150. PMC: 6022658. DOI: 10.1093/bioinformatics/bty266. View

Long H, Miller S, Strauss C, Zhao C, Cheng L, Ye Z . Antibiotic treatment enhances the genome-wide mutation rate of target cells. Proc Natl Acad Sci U S A. 2016; 113(18):E2498-505. PMC: 4983809. DOI: 10.1073/pnas.1601208113. View

Terceti M, Vences A, Matanza X, Barca A, Noia M, Lisboa J . The RstAB System Impacts Virulence, Motility, Cell Morphology, Penicillin Tolerance and Production of Type II Secretion System-Dependent Factors in the Fish and Human Pathogen subsp. . Front Microbiol. 2019; 10:897. PMC: 6491958. DOI: 10.3389/fmicb.2019.00897. View

10.

Rodriguez-Bano J, Gutierrez-Gutierrez B, Machuca I, Pascual A . Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. Clin Microbiol Rev. 2018; 31(2). PMC: 5967687. DOI: 10.1128/CMR.00079-17. View

11.

Zhang J, Yang H, Zhang L, Lv Z, Yu M, Sy S . Comparative metabolomics reveal key pathways associated with the synergistic activities of aztreonam and clavulanate combination against multidrug-resistant . mSystems. 2023; 8(6):e0075823. PMC: 10734488. DOI: 10.1128/msystems.00758-23. View

12.

Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-60. PMC: 2705234. DOI: 10.1093/bioinformatics/btp324. View

13.

Maryam L, Khan A . Combination of aztreonam and cefotaxime against CTX-M-15 type β-lactamases: A mechanism based effective therapeutic approach. Int J Biol Macromol. 2018; 116:1186-1195. DOI: 10.1016/j.ijbiomac.2018.05.153. View

14.

Mallik P, Paul B, Rutherford S, Gourse R, Osuna R . DksA is required for growth phase-dependent regulation, growth rate-dependent control, and stringent control of fis expression in Escherichia coli. J Bacteriol. 2006; 188(16):5775-82. PMC: 1540068. DOI: 10.1128/JB.00276-06. View

15.

Battesti A, Majdalani N, Gottesman S . The RpoS-mediated general stress response in Escherichia coli. Annu Rev Microbiol. 2011; 65:189-213. PMC: 7356644. DOI: 10.1146/annurev-micro-090110-102946. View

16.

Tatusova T, DiCuccio M, Badretdin A, Chetvernin V, Nawrocki E, Zaslavsky L . NCBI prokaryotic genome annotation pipeline. Nucleic Acids Res. 2016; 44(14):6614-24. PMC: 5001611. DOI: 10.1093/nar/gkw569. View

17.

Nam D, Choi E, Kweon D, Shin D . The RstB sensor acts on the PhoQ sensor to control expression of PhoP-regulated genes. Mol Cells. 2010; 30(4):363-8. DOI: 10.1007/s10059-010-0126-8. View

18.

Banda M, Manzo R, Bustamante V . HilD induces expression of a novel Salmonella Typhimurium invasion factor, YobH, through a regulatory cascade involving SprB. Sci Rep. 2019; 9(1):12725. PMC: 6726612. DOI: 10.1038/s41598-019-49192-z. View

19.

Ali Azam T, Iwata A, Nishimura A, Ueda S, Ishihama A . Growth phase-dependent variation in protein composition of the Escherichia coli nucleoid. J Bacteriol. 1999; 181(20):6361-70. PMC: 103771. DOI: 10.1128/JB.181.20.6361-6370.1999. View

20.

Liu Y, Li S, Li W, Wang P, Ding P, Li L . RstA, a two-component response regulator, plays important roles in multiple virulence-associated processes in enterohemorrhagic O157:H7. Gut Pathog. 2019; 11:53. PMC: 6824119. DOI: 10.1186/s13099-019-0335-4. View